• Most Popular
  • Most Shared

India Ranbaxy says gets FDA nod for allergy drug

Mon Dec 31, 2007 4:41am EST

Stocks

   

MUMBAI, Dec 31 (Reuters) - Ranbaxy Laboratories Ltd (RANB.BO), India's top drug maker by sales, said on Monday it had received final approval from the U.S. Food and Drug Administration to make and sell cetirizine hydrochloride tablets.

Stocks

Cetirizine hydrochloride is a generic version of Pfizer Inc's (PFE.N) allergy drug Zyrtec.

Total annual market sales for cetirizine hydrochloride tablets were $1.3 billion, Ranbaxy said, citing IMS data. (Reporting by Devidutta Tripathy; editing by Charlotte Cooper)

Stocks


More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

» More Top News
Passengers pass security notices as they approach the departure gates at Gatwick Airport, in southern England December 28, 2009. REUTERS/Luke MacGregor

Travelers met with hassles

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

U.S.
Iranian protesters take a policeman away to a safe place after he was beaten by angry protesters during fierce clashes in central Tehran December 27, 2009. Credit: REUTERS/Stringer

Deaths, arrests in Iran

Is Iran's "iron fist of brutality" a new volatile phase aimed at crushing the refomist movement?  Full Article | Video 

World